A nurse is caring for a patient diagnosed with rheumatic fever who presents with erythema marginatum, subcutaneous nodules, and a diastolic murmur. Which intervention should the nurse prioritize to prevent further cardiac damage?

B) Initiate azithromycin therapy as ordered

A) Administer NSAIDs as prescribed

B) Initiate azithromycin therapy as ordered

C) Monitor for signs of heart failure

D) Educate the patient about activity restrictions

A patient diagnosed with rheumatic fever presents with erythema marginatum, subcutaneous nodules, and mild mitral valve regurgitation. Given the patient's penicillin allergy, which nursing intervention is most appropriate to prevent further cardiac complications?

C) Administer azithromycin as prescribed and monitor for signs of antibiotic side effects.

A) Administer aspirin for pain management and inflammation control.

B) Monitor for signs of congestive heart failure and educate the patient on fluid restriction.

C) Administer azithromycin as prescribed and monitor for signs of antibiotic side effects.

D) Initiate bed rest to reduce cardiac workload and monitor vital signs closely.

A patient with worsening mitral valve regurgitation is experiencing signs of heart failure, including increasing fatigue and shortness of breath. Her treatment plan includes the initiation of furosemide therapy. Which nursing intervention is most critical to monitor for potential complications associated with this therapy?

C) Monitor the patient's electrolyte levels, specifically potassium.

A) Monitor the patient's respiratory rate and breath sounds regularly.

B) Assess the patient's blood glucose levels frequently.

C) Monitor the patient's electrolyte levels, specifically potassium.

D) Evaluate the patient's pain level and administer analgesics as needed.

A patient with worsening mitral valve regurgitation and symptoms of heart failure has been started on furosemide therapy. As the nurse, which of the following interventions should you prioritize to monitor the effectiveness of the treatment and prevent complications?

A) Measure the patient's weight daily and monitor intake and output.

B) Encourage the patient to increase fluid intake to promote diuresis.

C) Monitor the patient's blood pressure every 8 hours and adjust medications accordingly.

D) Administer potassium supplements with each dose of furosemide to prevent hypokalemia.

A patient with a history of rheumatic heart disease is being treated with diuretics and metoprolol for symptoms of fluid overload and tachycardia. Her serum potassium level is 3.2 mmol/L. Which nursing intervention is the most appropriate to address this electrolyte imbalance while continuing her current treatment regimen?

C) Administer prescribed potassium supplements and monitor the serum potassium level.

A) Encourage the patient to consume potassium-rich foods.

B) Hold the metoprolol until the potassium level normalizes.

C) Administer prescribed potassium supplements and monitor the serum potassium level.

D) Increase the dose of diuretics to promote further diuresis.

A patient with rheumatic heart disease is being treated with diuretics and metoprolol. The nurse notes a weight decrease of 2 kilograms, a serum potassium level of 3.2 mmol/L, and an elevated heart rate of 105 beats per minute. Which of the following actions should the nurse prioritize?

B) Notify the healthcare provider about the low potassium level.

A) Continue current treatment and monitor vital signs closely.

B) Notify the healthcare provider about the low potassium level.

C) Educate the patient on a low-sodium diet to reduce fluid retention.

D) Withhold metoprolol until the heart rate decreases to normal.

A patient with moderate mitral valve regurgitation, mild anemia, and mild left ventricular hypertrophy is being managed with metoprolol and diuretics. Which nursing intervention is most appropriate to monitor and address potential complications associated with this treatment regimen?

A) Monitor blood pressure and heart rate closely to prevent hypotension and bradycardia.

B) Educate the patient on increasing their fluid intake to prevent dehydration.

C) Schedule regular echocardiograms to assess the progression of mitral valve regurgitation.

D) Encourage the patient to reduce physical activity to prevent fatigue and dyspnea.

A patient with moderate mitral valve regurgitation and mild anemia is experiencing fatigue, occasional palpitations, and a heart rate of 95 bpm after starting metoprolol. Which nursing intervention is most appropriate to address the patient's current symptoms and lab findings?

D) Monitor renal function closely and adjust diuretics as needed.

A) Increase the dosage of metoprolol to further reduce heart rate.

B) Educate the patient on dietary modifications to address anemia.

C) Encourage the patient to increase physical activity despite fatigue.

D) Monitor renal function closely and adjust diuretics as needed.

A patient with worsening mitral valve regurgitation and anemia presents with fatigue and shortness of breath. Her blood pressure is 100/60 mmHg, and serum creatinine is 1.5 mg/dL. Which nursing intervention is the most appropriate to address her symptoms and prevent complications?

D) Collaborate with the healthcare team to adjust antihypertensive medications to prevent hypotension

A) Increase the dosage of her diuretic to reduce fluid overload

B) Educate the patient on the importance of iron supplementation for anemia management

C) Administer a blood transfusion to immediately improve hemoglobin levels

D) Collaborate with the healthcare team to adjust antihypertensive medications to prevent hypotension

A patient with worsening mitral valve regurgitation, left atrial enlargement, and worsening anemia presents with fatigue and more frequent episodes of shortness of breath. Her blood pressure is 100/60 mmHg, and her serum creatinine has risen slightly. Which of the following nursing interventions is most appropriate to address her current symptoms and stabilize her condition?

B) Administer supplemental oxygen and encourage rest to reduce cardiac workload.

A) Increase the dosage of her antihypertensive medications to manage her blood pressure.

B) Administer supplemental oxygen and encourage rest to reduce cardiac workload.

C) Increase the diuretic dosage to manage fluid status and reduce cardiac preload.

D) Encourage the patient to increase physical activity to improve cardiac output.

RHEUMATIC FEVER AND RHEUMATIC DISEASE - Nursing Case Study

Pathophysiology

• Primary mechanism: Rheumatic fever is triggered by an autoimmune response to Group A Streptococcus infection, where antibodies against bacterial antigens mistakenly attack host tissues, especially in the heart, joints, skin, and brain.

• Secondary mechanism: Molecular mimicry plays a crucial role, as streptococcal M protein shares structural similarities with cardiac myosin, leading to cross-reactivity and inflammation of the heart's endocardium, myocardium, and pericardium.

• Key complication: This immune-mediated damage can result in rheumatic heart disease, characterized by chronic valvular deformities, most commonly affecting the mitral valve, which may lead to heart failure and increased risk of infective endocarditis.

Patient Profile

Demographics:

16-year-old female, high school student

History:

• Key past medical history: Previous streptococcal throat infections, no prior history of rheumatic fever

• Current medications: None

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Joint pain and swelling

• Key symptoms: Fever, fatigue, shortness of breath, chest pain, and migrating polyarthritis

• Vital signs: Temperature 101°F, heart rate 110 bpm, blood pressure 100/60 mmHg, respiratory rate 22 breaths per minute

Section 1

As the case unfolds, the initial assessment findings indicate a progression of the condition. Upon physical examination, the patient presents with a noticeable erythematous rash on her trunk and proximal limbs, known as erythema marginatum. The rash is characterized by its serpiginous and painless nature, further supporting the diagnosis of rheumatic fever. Cardiac auscultation reveals a new onset of a soft, high-pitched diastolic murmur at the apex, suggestive of mitral valve involvement, likely mitral regurgitation due to valvular inflammation. The presence of subcutaneous nodules over the extensor surfaces of her joints further corroborates the suspicion of rheumatic fever.

Laboratory results show elevated inflammatory markers, including an erythrocyte sedimentation rate (ESR) of 75 mm/hr and a C-reactive protein (CRP) level of 10 mg/dL, indicating significant systemic inflammation. An echocardiogram is performed, revealing mild mitral valve regurgitation with slight thickening and prolapse of the mitral valve leaflets, consistent with rheumatic heart disease. The patient also demonstrates a prolonged PR interval on her ECG, signifying first-degree heart block, a common cardiac manifestation in rheumatic fever.

The change in the patient's status necessitates immediate interventions to prevent further cardiac damage and manage symptoms. She is started on a course of non-steroidal anti-inflammatory drugs (NSAIDs) for joint pain and inflammation, while her fever is managed with antipyretics. Given her allergy to penicillin, an alternative antibiotic, such as azithromycin, is initiated to eradicate any residual streptococcal infection and prevent recurrence. Due to the potential for progression to more severe cardiac complications, the healthcare team closely monitors her cardiac function and adjusts her treatment plan accordingly. These interventions aim to stabilize her condition and prevent long-term sequelae, such as the progression to severe rheumatic heart disease or heart failure.

Section 2

As the treatment progresses, the patient begins to show signs of new complications. Despite initial management efforts, she develops increasing fatigue and shortness of breath, which prompts further investigation. A repeat physical examination reveals mild jugular venous distention and bibasilar crackles upon auscultation of the lungs, indicating possible fluid overload. Her vital signs show a heart rate of 110 beats per minute, blood pressure of 100/60 mmHg, and respiratory rate of 24 breaths per minute. These findings suggest the development of heart failure, likely a consequence of worsening mitral valve regurgitation.

A follow-up echocardiogram is performed, revealing an increase in the severity of the mitral valve regurgitation, with an ejection fraction now decreased to 45%, suggesting impaired left ventricular function. Laboratory results show a B-type natriuretic peptide (BNP) level elevated to 350 pg/mL, consistent with heart failure. The decision is made to initiate diuretic therapy with furosemide to manage her symptoms of volume overload, alongside close monitoring of her electrolytes and renal function.

The healthcare team discusses the possibility of surgical intervention if medical management proves insufficient, considering the potential need for mitral valve repair or replacement. The patient's changing clinical status requires ongoing reassessment and collaboration among the cardiology, rheumatology, and nursing teams to ensure the best possible outcomes. This situation underscores the importance of timely intervention and vigilant monitoring to prevent further deterioration and to provide comprehensive care tailored to the patient's evolving needs.

Section 3

As the diuretic therapy is initiated, the patient's response is closely monitored. Within 48 hours, there is a noticeable improvement in her symptoms of fluid overload. The patient's jugular venous distention decreases, and the bibasilar crackles diminish, indicating a reduction in pulmonary congestion. Her weight decreases by 2 kilograms, suggesting effective diuresis. However, the healthcare team remains vigilant, as diuretic therapy can lead to electrolyte imbalances. Repeat laboratory tests reveal a slight decrease in serum potassium levels to 3.2 mmol/L, prompting the addition of potassium supplements to prevent hypokalemia.

Despite these improvements, the patient still experiences episodes of fatigue and occasional shortness of breath, albeit less severe than before. Her heart rate remains elevated at 105 beats per minute, and her blood pressure has stabilized at 110/65 mmHg. The team decides to introduce a beta-blocker, metoprolol, to help manage her heart rate and potentially improve her left ventricular function. This decision is made with caution, considering the potential for further lowering her blood pressure.

The patient's clinical status remains a topic of ongoing discussion among the multidisciplinary team. There is a consensus that while the medical management has provided some relief, the persistent mitral valve regurgitation may necessitate surgical consideration. The cardiology team schedules a meeting with the patient and her family to discuss the potential benefits and risks of surgical intervention, including mitral valve repair or replacement. This collaborative approach ensures that the patient is well-informed and involved in the decision-making process, highlighting the importance of patient-centered care in complex cases of rheumatic heart disease.

Section 4

As the patient continues under close observation, a new set of diagnostic results reveals further insights into her condition. An echocardiogram is performed to assess the severity of the mitral valve regurgitation and the overall function of the heart. The findings indicate a moderate degree of mitral valve regurgitation, with some evidence of left atrial enlargement and mild left ventricular hypertrophy. These findings suggest that the heart is working harder to compensate for the valve dysfunction, which could explain the patient's persistent fatigue and occasional shortness of breath.

Further laboratory tests reveal a mild anemia, with hemoglobin levels at 10.5 g/dL, which may be contributing to her symptoms of fatigue. Additionally, the patient's serum creatinine has slightly increased to 1.3 mg/dL, raising concerns about potential renal implications of the current pharmacologic regimen, particularly with the introduction of metoprolol and ongoing diuretic therapy. This prompts the healthcare team to adjust the diuretic dosage and closely monitor renal function.

The patient reports feeling slightly more energetic, although she still experiences occasional palpitations. Her heart rate has decreased to 95 beats per minute since starting metoprolol, indicating a positive response to the beta-blocker. However, the team remains vigilant about the risks of hypotension and renal impairment. This new information leads to a multidisciplinary discussion about the need for a comprehensive management plan that balances the risks and benefits of ongoing medical therapy while considering the timing of potential surgical intervention. The patient's overall stability allows for a thoughtful approach to her care, emphasizing the importance of regular reassessment and patient involvement in decision-making to optimize long-term outcomes.

Section 5

As the patient's care continues, a new set of diagnostic results highlights emerging concerns. A follow-up echocardiogram reveals a slight progression in the mitral valve regurgitation, now edging towards severe, with more pronounced left atrial enlargement. The left ventricular hypertrophy also appears slightly more significant, indicating increased cardiac workload. These cardiac changes correlate with the patient's persistent symptoms of fatigue and now more frequent episodes of shortness of breath. Additionally, the patient's blood pressure has shown a tendency to dip, with a recent reading at 100/60 mmHg, necessitating careful titration of her antihypertensive regimen to prevent symptomatic hypotension.

Further laboratory evaluations indicate a worsening anemia, as her hemoglobin has decreased to 9.8 g/dL. This drop in hemoglobin suggests an ongoing process that might be contributing to her fatigue and decreased exercise tolerance. Concurrently, her serum creatinine has risen slightly to 1.5 mg/dL, raising further concerns about renal function. The medical team decides to adjust her diuretic therapy cautiously and consider alternative strategies to manage her fluid status and blood pressure while minimizing renal strain.

In light of these developments, the healthcare team initiates a more aggressive monitoring protocol, including daily weight checks, frequent vital signs assessments, and repeat laboratory tests to closely monitor her renal function and cardiac status. The team engages in a detailed discussion with the patient about the potential need for surgical intervention, such as valve repair or replacement, given the progression of her cardiac condition. This dialogue emphasizes the importance of shared decision-making, considering the patient's values and preferences alongside clinical indications, to ensure a patient-centered approach to her care. The aim is to stabilize her condition effectively while planning for long-term management strategies that address both her cardiac and renal health.